Physician profile
William Gregory Lensing
NPI 1982612990
$9,465.46
in general payments reported to CMS, 2019-2025
53 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,831 · 2020: $412 · 2021: $1,212 · 2022: $1,818 · 2023: $1,463 · 2024: $1,530 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,193.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,294.55 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,248.92 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $906.58 | 2019-2025 | |
| Glaxosmithkline, LLC. | $813.12 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $491.16 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $472.95 | 2019-2024 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.04 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $344.87 | 2019-2023 | |
| Biohaven Pharmaceuticals, INC. | $314.44 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $305.68 | 2019-2023 | Steglatro, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $278.40 | 2022-2025 | |
| Pfizer INC. | $174.84 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $173.01 | 2019-2025 | Spravato |
| Exact Sciences Corporation | $161.23 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $146.20 | 2022 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $144.18 | 2020-2021 | |
| Corium, LLC | $137.96 | 2022-2023 | Azstarys |
| Alexion Pharmaceuticals, INC. | $127.14 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $125.18 | 2022-2024 | Quviviq |
| Astellas Pharma US INC | $118.28 | 2020-2025 | Veozah |
| Dexcom, INC. | $93.71 | 2024-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $91.53 | 2021-2022 | |
| Antares Pharma, INC. | $82.75 | 2021-2024 | Xyosted |
| Genentech USA, INC. | $77.29 | 2020-2022 | |
| Itamar Medical INC | $74.60 | 2022-2023 | Watchpatone |
| Abbott Laboratories | $74.43 | 2021-2025 | Freestyle Libre 3 |
| Eisai INC. | $70.95 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $65.67 | 2021-2023 | Unithroid |
| Sanofi-Aventis U.S. LLC | $61.26 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $60.76 | 2019-2020 | |
| Radius Health, INC. | $49.62 | 2019-2020 | |
| Clarus Therapeutics INC. | $49.13 | 2021 | |
| Lundbeck LLC | $36.07 | 2023-2025 | Vyepti, Rexulti |
| Tolmar, INC. | $33.48 | 2023 | |
| Coloplast Corp | $33.40 | 2021 | |
| Ibsa Pharma INC. | $32.59 | 2019-2023 | Tirosint, Licart |
| Sanofi Pasteur INC. | $31.39 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.05 | 2022-2023 | Cycloset |
| Boston Scientific Corporation | $30.84 | 2023 | Wavewriter Alpha Prime 16 |
| Mayne Pharma Commercial LLC | $24.75 | 2025 | |
| Sandoz INC. | $23.46 | 2024 | |
| Qol Medical, LLC | $23.05 | 2024 | Sucraid |
| Siemens Medical Solutions USA, INC. | $22.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.63 | 2022 | |
| Inari Medical, INC. | $19.36 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Dynavax Technologies Corporation | $19.18 | 2023 | Heplisav-B |
| Spr Therapeutics, INC | $18.05 | 2024 | Sprint Pns System |
| Nestle Healthcare Nutrition INC. | $17.83 | 2023 | |
| Jazz Pharmaceuticals INC. | $15.42 | 2022 | |
| Kyowa Kirin, INC. | $15.18 | 2025 | |
| Azurity Pharmaceuticals, INC. | $14.02 | 2023 | Edarbyclor |
| Novartis Pharmaceuticals Corporation | $12.22 | 2021 | |
| Shire North American Group INC | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lensing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.